Previous Close | 0.7514 |
Open | 0.7310 |
Bid | 0.7060 x 100 |
Ask | 0.7801 x 100 |
Day's Range | 0.7050 - 0.7700 |
52 Week Range | 0.6600 - 7.4800 |
Volume | |
Avg. Volume | 100,353 |
Market Cap | 17.905M |
Beta (5Y Monthly) | -0.09 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.4800 |
Earnings Date | Nov 13, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | May 24, 2022 |
1y Target Est | 18.50 |
New York, NY, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Diamond Equity Research, an equity research firm with a focus on small capitalization public companies has released an Update Note on ProPhase Labs Inc. (NASDAQ: PRPH). The update note includes information on ProPhase’s business model, services offered, industry outlook, financial results, management commentary, valuation, and risks. The update note is available below. ProPhase Labs November 2024 Update Note Highlights from the note include: Launch
ProPhase Labs (PRPH) delivered earnings and revenue surprises of -12.90% and 11.56%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?